Digital Media Net - Your Gateway To Digital media Creation. News and information on Digital Video, VR, Animation, Visual Effects, Mac Based media. Post Production, CAD, Sound and Music
Categories: News

Genflow Biosciences PLC Announces Holding(s) in Company

LONDON, UK / ACCESS Newswire / October 24, 2025 / TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BP2C3V08

Issuer Name

GENFLOW BIOSCIENCES PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Jonathan Mark Swann

City of registered office (if applicable)

rickmansworth

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached

23-Oct-2025

6. Date on which Issuer notified

23-Oct-2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

11.320000

0.000000

11.320000

55861278

Position of previous notification (if applicable)

8.400000

0.000000

8.400000

36588550

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BP2C3V08

55861278

0

11.320000

0.000000

Sub Total 8.A

55861278

11.320000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

NONE

12. Date of Completion

23-Oct-2025

13. Place Of Completion

London

Contacts

Genflow Biosciences

Harbor Access

Dr Eric Leire, CEO

Jonathan Paterson, Investor Relations

+32-477-495-881

+1 475 477 9401

Jonathan.Paterson@Harbor-access.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Genflow Biosciences PLC

View the original press release on ACCESS Newswire

Staff

Recent Posts

Roland DG Announces North American Launch of the EU2-1000MF, Simplifying High-Output Board Production With Direct-to-Board UV Flatbed Printing

The new EU2-1000MF delivers higher productivity and a more predictable productionworkflow for sign and display…

26 minutes ago

Pixelworks to Announce Second Quarter 2026 Financial Results on August 11

PORTLAND, Ore., July 28, 2026 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ: PXLW), a provider of innovative…

26 minutes ago

Happiest Minds Reports Strong Start to FY27 with Revenues of ₹629 Crores, Up 14.3% y-o-y; With Operating margins growing at 11.8% y-o-y

BENGALURU, India, SEATTLE and LONDON, July 28, 2026 /PRNewswire/ -- Happiest Minds Technologies Limited (NSE:…

26 minutes ago

New Labster Research Reveals a Confidence Gap Threatening Online STEM Program Retention, Points to Missing Experiential Learning as a Fixable Cause

A research study of online and hybrid STEM students finds a persistent gap between the…

26 minutes ago

O’Shaughnessy Ventures Backs Filmmaker Exploring the Human Relationship with Technology

Donald Jewkes receives an O'Shaughnessy Fellowship to produce original documentaries and narrative shorts about the…

26 minutes ago

TAG/ANA/ Fiducia Analysis Quantifies Level of “AI Slop” in Digital Advertising Supply Chain for First Time

Part of ANA Programmatic Transparency Benchmark Initiative, Analysis Finds AI Slop Accounts for 1.3%-2.4% of…

9 hours ago